𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Palivizumab for respiratory syncytial virus prophylaxis in high-risk infants: a cost-effectiveness analysis

✍ Scribed by Jennifer H. Lofland; Suzanne M. Touch; John P. O'Connor; Mary Lou Chatterton; Elizabeth D. Moxey; Lisa E. Paddock; David B. Nash; Shobhana A. Desai


Book ID
117320911
Publisher
Elsevier Science
Year
2000
Tongue
English
Weight
890 KB
Volume
22
Category
Article
ISSN
0149-2918

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES